The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I

Clinical trial NCT04898010 · SUSPENDED

Trial details

NCT number: NCT04898010
Sponsor: Lenar Yessayan
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Kidney Injury Hepatorenal Syndrome

Start date: 2022-06-09
Primary completion: 2027-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.